The Great Place for all lake forest health and fitness | island health and fitness | health and fitness blogs Health and Fitness Blog Information and News.
Tuesday, 11 October 2016
Schizophrenia patient's fear over psychiatric ward closure
Virus steals black widow poison gene to help it attack
France's first drug room for addicts to inject opens in Paris
Passport checks for pregnant NHS patients
Experts warn of obesity upsurge within a decade
| 2.7 billion adults worldwide will be overweight by 2025 Related items from OnMedica Obesity fight undermined by budget cuts General public unaware of link between obesity and cancer Obesity gap between rich and poor children set to rise Managing obesity in primary care - Part 2 Managing obesity in primary care - Part 1 |
Absentee parent link to smoking and drinking before adolescence
| Children more than twice as likely to smoke before teenage years if parent is missing Related items from OnMedica The health needs of the teenager Make health services more teen friendly and accessible, says WHO Alcohol adverts shown every 72 seconds during Euro 2016 Half of parents let children drink alcohol at home Commission more teen mental health and alcohol services |
World Health Organisation backs tax on sugary foods and drinks
Testosterone for menopausal women
Patients put off seeing GPs by receptionists’ questions
| 40% of patients say receptionists deter them from seeing GP Related items from OnMedica Meeting cancer promises and more – a new model for NHS diagnostics? Better GP receptionist training might boost patient experience/satisfaction BMA calls for maximum number of patients per GP Hunt promises to expand NHS digital services |
Zika virus highly likely to spread in Asia, says WHO
NHS not transgender-friendly enough, says nurse
Young ovaries rejuvenate older mice and extend their lifespan
Diabetes prescriptions rise by a third in last five years
| Experts predict 5 million type 2 diabetes diagnoses in 2020 Related items from OnMedica Glycosylated haemoglobin (HbA1c) and screening for diabetes Overview of type 1 diabetes Diabetes drugs costs NHS England nearly £1bn a year Intensive treatment of type 2 diabetes with microalbuminuria reaps benefits 3.8 million people in England have diabetes |
Obesity gap between rich and poor children set to rise
| 60% of deprived boys set to be obese by 2020 Related items from OnMedica Obesity in childhood Childhood obesity plan attacked as 'weak' and 'watered down' Stronger rules needed over junk food advertising Levy on sugary drinks announced in Budget Fruit drinks for children have ‘unacceptably high’ sugar levels |
WHO urges global action to curtail consumption and health impacts of sugary drinks
Receptionists 'put people off seeing doctor'
Monday, 10 October 2016
4 Healthy Packaged Snacks We're Loving Now
Snacks are a big thing in the EatingWell office. Whether it's homemade treats from the Test Kitchen (perks of the job) or rummaging through a snack drawer, people are always snacking here. And that's a good thing: choosing healthy snacks with protein, fiber and nutrients helps make sure you fill up between meals, so you aren't tempted to overeat later in the day. Just don't go overboard on calories or sodium with your snack choices (watch out for that vending machine).
Haiti faces famine and disease in aftermath of hurricane
Third of young people with mental health issues stigmatised
| More than half unwilling to seek professional help Related items from OnMedica Community mental health services Mental health services for children inadequate Mental health support to be launched for GPs ‘No improvement’ in community mental health care |
How much water should you drink a day? Your throat will tell you
Exclusive: ‘3-parent’ baby method already used for infertility
Challenging Goal? Improve Focus by Engaging Your Brain
New research confirms anecdotal observations that people can easily be distracted if they want to be, and that the ability to concentrate on a task and stay disciplined is best accomplished when an individual is interested.
Investigators say their findings provide evidence that one’s motivation is just as important for sustained attention to a task as is the ease with which the task is done.
The research also challenges the hypothesis, proposed by some cognitive neuroscientists, that people become more distractible as they tackle increasingly difficult tasks.
A report of the new study appears in the Journal of Experimental Psychology: General. The authors of the study, University of Illinois psychology professors Drs. Simona Buetti and Alejandro Lleras write:
People must almost continuously balance their need for inner focus (reflection, mental effort) with their need for attending to the world. But, when the need for inner focus is high, we may have the impression that we momentarily disengage from the world entirely in order to achieve a heightened degree of mental focus.
Buetti and Lleras designed several experiments to test whether people are more easily distracted when the mental effort required to complete a task goes up, as is generally assumed in their field.
The researchers first asked participants to solve math problems of varying difficulty while photographs of neutral scenes — for example, cows in a pasture, a portrait of a man, a cup on a table — flashed on a computer display for three seconds, enticing the subjects to look at them.
An eye-tracking device measured the frequency, speed, and focus of participants’ eyes as they completed the math problems.
The results showed that participants who were engaged in an easy version of the task were more likely to look at the distractors than those engaged in an extremely challenging version. These results run counter to current theories, the researchers said. As put by Buetti:
This suggests that focus on complex mental tasks reduces a person’s sensitivity to events in the world that are not related to those tasks
This finding corresponds to research on a phenomenon called “inattentional blindness,” in which people involved in an engaging task often fail to notice strange and unexpected events. As put by the authors:
Between the inner world of solving a problem and the outer world — what’s going on around you — there seems to be a need to disengage from one when heightened attention to the other is required…Interestingly, when participants completed a mix of easy and hard tasks, the difficulty of the task did not seem to affect their distractibility.
This finding led the researchers to hypothesize that the ability to avoid being distracted is not driven primarily by the difficulty of the task, but is likely the result of an individual’s level of engagement with the endeavor. They call this concept the “engagement theory of distractibility.”
The team did further studies to test this idea, manipulating subjects’ enthusiasm for the task with financial incentives. To the researchers’ surprise, this manipulation had little effect on participants’ distractibility. However, as explained by Buetti there were large differences between people in terms of their distractibility:
The more participants struggled with a task, the more they reflexively avoided distraction, irrespective of financial incentive. So, the take-home message is: Characteristics of the task itself, like its difficulty, do not alone predict distractibility. Other factors also play a role, like the ease with which we can perform a task, as well as a decision that is internal to each of us: how much we decide to cognitively engage in a task.
This guest article originally appeared on PsychCentral.com: Motivation Linked to Ability to Stay on Task by Rick Nauert PhD.
References
Buetti, S., & Lleras, A. Distractibility is a function of engagement, not task difficulty: Evidence from a new oculomotor capture paradigm. (2016). Journal of Experimental Psychology: General, 145(10), 1382–1405. doi:10.1037/xge0000213
via Brain Blogger Read More Here..Plan to boost doctor numbers contains ‘risk’ to NHS
| Quarter of NHS doctors from overseas still needed, say leaders Related items from OnMedica Shortage of critical beds and surgeons cause cancelled ops Practices struggling to recruit can access up to £12K Workloads high and not always enough experienced staff, say doctors Medical training places to increase by 25% NHS faces unpredictable outcomes following Brexit vote |
Drug could double head and neck cancer survival
| Trial suggests immunotherapy drugs prolongs survival Related items from OnMedica New technique helps curb dry mouth in head and neck cancer patients Depressed head and neck cancer patients have poorer survival Ditch habit for longer survival after head and neck cancer, smokers urged NICE green lights new cancer drugs for NHS Study shows huge global variation in cancer drug costs |
Guide launched to ease stress on GPs
| Advice on spotting stressors before GPs burn out Related items from OnMedica Health for Health Professionals Health for Health Professionals Health for Health Professionals Staff burnout could derail the NHS’s drive for efficiency NHS pressures could cause staff ‘burnout’ |
Leaders call for major rethink on NHS
| Manifesto calls for major shift of care to community Related items from OnMedica Multispecialty community provider contract options unveiled What does it mean to be a Multispecialty Community Provider? Five-year plan for general practice unveiled It ‘beggars belief’ that seven-day NHS plans are uncosted, say MPs Pressure makes diamonds |
Immunotherapy cancer drug hailed as 'game changer'
Type 2 diabetes: Data reveals hotspots for cases
Sunday, 9 October 2016
Cancer drug 'helped me totally enjoy life'
Saturday, 8 October 2016
New Target in Brain for Treating Depression — The BMP Pathway
A significant number of patients do not respond to antidepressant drugs, and some even feel worse, a somber fact that emphasizes the urgent need to find other treatment options.
In a new study on mice, scientists at Northwestern Medicine have discovered a pathway in the brain that may be a promising new drug target for people with non-responsive depression.
Sarah Brooker, the first author and an M.D./Ph.D student at Northwestern University Feinberg School of Medicine explains:
Identifying new pathways that can be targeted for drug design is an important step forward in improving the treatment of depressive disorders
Brooker conducted the study in the lab of senior study author Dr. Jack Kessler, a professor of neurology at Feinberg and a Northwestern Medicine neurologist.
The aim of their research is to gain a better understanding of how current antidepressants work in the brain, with the ultimate goal of finding new drug targets that are more effective for people who do not respond to current medications.
During the study, scientists discovered for the first time that antidepressant drugs such as Prozac and tricyclics target a pathway in the hippocampus called the BMP signaling pathway. A signaling pathway is a group of molecules in a cell that work together to control one or more cell functions.
Like a cascade, after the first molecule in a pathway receives a signal, it activates another molecule and so forth until the cell function is carried out.
The researchers found that Prozac and tricyclics inhibit this pathway and, thereby, trigger stem cells in the brain to produce more neurons responsible for mood and memory formation. However, the researchers didn’t know if blocking the pathway contributed to the drugs’ antidepressant effect because Prozac acts on multiple mechanisms in the brain.
After confirming the importance of the BMP pathway in depression, the scientists investigated a brain protein, called Noggin, on depressed mice. Noggin is known to block the BMP pathway and stimulate new neurons, a process known as neurogenesis.
They discovered Noggin blocks the pathway more precisely and effectively than Prozac or tricyclics, as the mice soon experienced a strong antidepressant effect.
A sign of depression in mice is a tendency to hang lifelessly when held by the tail, rather than struggle to get themselves upright. After receiving Noggin, mice energetically tried to lift themselves up, whereas control mice were more likely to give up and just hang there.
The mice were then placed in a maze with secluded (safe) and open (less safe) spaces. The Noggin mice were less anxious and explored more mazes than the control mice.
As put by Kessler, also the Ken and Ruth Davee Professor of Stem Cell Biology:
The biochemical changes in the brain that lead to depression are not well understood, and many patients fail to respond to currently available drugs. Our findings may not only help to understand the causes of depression, but also may provide a new biochemical target for developing more effective therapies.
This guest article originally appeared on PsychCentral.com: Scientists Target New Pathway in Brain to Alleviate Depression by Traci Pedersen.
Reference
Brooker, S. M., Gobeske, K. T., Chen, J., Peng, C.-Y., & Kessler, J. A. (2016). Molecular psychiatry – abstract of article: Hippocampal bone morphogenetic protein signaling mediates behavioral effects of antidepressant treatment. Molecular Psychiatry. doi:10.1038/mp.2016.160
via Brain Blogger Read More Here..Friday, 7 October 2016
Ollie Gardiner: Bid to raise £100k for cancer treatment for boy, 12
Mental health support to be launched for GPs
Revamp speeds up GP return to practice
Mental health needs better management in criminal justice system
| NICE draws up guidance to improve treatment and assessment Related items from OnMedica Mental health services for children inadequate Health bodies to bid for mental health ‘safe places’ fund Mental health charities merge Volunteering after 40 enhances mental health Commission more teen mental health and alcohol services |
Doctors warn of alternative therapy risk for children
| Holistic supplement use led to A&E admission Related items from OnMedica GPs sign up to cut use of ‘chemical restraint’ NICE publishes standards to improve autism care Welsh Government plan to improve autism services New gene identified linked to autism Some children ‘outgrow’ earlier diagnosed autism |
Tamoxifen linked to reduce contralateral breast cancer risk
| Women should complete full course, say study authors Related items from OnMedica Breast cancer drug ‘too costly’ for NHS Fertility treatments may impact on breast cancer risk Ten year hormonal therapy cuts breast cancer relapse Breast cancer and HRT Women denied cheap drug to stop breast cancer spread |
Warning given over children using complementary therapies
Woman's giant 'Rapunzel syndrome' hairball cut out of stomach
Thursday, 6 October 2016
How brain cells move through newborn babies’ brains
New Game-like Technology Helps Assess Concussions
In August, the FDA approved two medical devices that can assess cognitive function immediately after a suspected brain injury or concussion. These tests are the first of their kind that the FDA has allowed to be marketed.
The tests – Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) and ImPACT Pediatric – are the first devices permitted for marketing that assess cognitive function following a potentially concussive injury. Both tests are intended to be used as part of a complete medical evaluation by physicians or other health care personnel trained in assessing signs and symptoms of head injury; the tests are not intended to diagnose concussion or determine possible treatments.
ImPACT is conducted on a desktop or laptop and is designed for patients aged 12 to 59. The more game-like, ImPACT Pediatric, is conducted on a tablet and is designed for patients aged 5 to 11. The tests assess cognitive skills such as word memory, attention span, nonverbal problem solving, and reaction time; the results are compared to an age-matched control database or a patient’s pre-injury scores, if any are available. The manufacturer – ImPACT Applications in Pittsburgh, Pennsylvania – reports that they currently have 17,000 cases in the normative, control database.
In order to gain FDA approval of ImPACT and ImPACT Pediatric, the manufacturer submitted results of more than 250 peer-reviewed device analyses. More than half of these were independent, clinical research studies. Together, the studies resolved that the devices were valid and reliable and able to detect evidence of cognitive dysfunction. The FDA determined that ImPACT and ImPACT Pediatric were safe and effective. Therefore, the results supported the marketing of the devices through a de novo classification process – a regulatory pathway for new, low- to moderate-risk medical devices that are the first of their kind.
Traumatic brain injuries (TBI) account for more than 2 million emergency department visits each year in the United States. More than 50,000 Americans die from TBI annually. Concussion, a subset of mild TBI, is a traumatically induced transient disturbance of brain function that involves a complex pathophysiologic process. As many as 3.8 million concussions occur during competitive and recreational sports in the United States, but approximately half go unreported.
Concussions, especially in sports and the military, are common. However, they are difficult to diagnose, and under-reporting remains a public health burden. Many systems for preventing, assessing, and treating concussions are being investigated and developed, but many questions remain unanswered. Long-term consequences of concussion are still unclear, as well, with pervasive alterations in attention and executive control apparent after a single concussive incident during childhood.
Concussion is a clinical diagnosis that must be made by a health care provider who is familiar with the patient and can recognize and evaluate a concussion. Symptom checklists are objective for evaluating a variety of symptoms related to a head injury, and some standardized assessment tools offer structure for evaluating concussion. Biomarkers are being investigated as potential diagnostic and prognostic tools. Much more research is needed to validate current assessments, and new technologies may provide new insight for diagnosing, evaluating, and managing concussions.
Any mechanism, including the new ImPACT systems, that can raise awareness of concussion and assist in identifying cognitive injury, may offer an important direction for combating concussive injuries in the future.
References
Brennan JH, Mitra B, Synnot A, et al. Accelerometers for the assessment of concussion in male athletes: a systematic review and meta-analysis (2016) Sports Medicine. Epub ahead of print. PMID: 27402455
Brett BL, Smyk N, Solomon G, et al. Long-term stability and reliability of baseline cognitive assessments in high school athlete using ImPACT at 1-, 2-, and 3-year test-retest intervals (2016) Archives of Clinical Neuropsychology. Epub ahead of print. PMID: 27538440
Crowe L, Collie A, Hearps S, et al. Cognitive and physical symptoms of concussive injury in children: a detailed longitudinal recovery study (2016) British Journal of Sports Medicine, 50(5):311-6. PMID: 26429808
Faltus J, Huntimer B, Kernozek T, Cole J. Utilization of ImPACT testing to measure injury risk in alpine ski and snowboard athletes (2016) International Journal of Sports Physical Therapy, ;11(4):498-506. PMID: 27525174
Finkbeiner NW, Max JE, Longman S, Debert C. Knowing what we don’t know: long-term psychiatric outcomes following adult concussion in sports. Canadian Journal of Psychiatry. 2016;61(5):270-6. PMID: 27254801
Harmon KG, Drezner JA, Gammons M, et al. American Medical Society for Sports Medicine position statement: concussion in sport (2013) British Journal of Sports Medicine, 47(1):15-26. PMID: 23243113
Kroshus E, Garnett BR, Baugh CM, Calzo JP. Engaging teammates in the promotion of concussion help seeking (2016) Health Education & Behavior, 43(4):442-51. PMID: 27405801
Moore DR, Pindus DM, Raine LB, et al. The persistent influence of concussion on attention, executive control and neuroelectric function in preadolescent children (2016) International Journal of Psychophysiology, 99:85-95. PMID: 26608697
U.S. Food and Drug Administration. FDA allows marketing of first-of-king computerized cognitive tests to help assess cognitive skills after a head injury. News release. August 22, 2016. http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm517526.htm.
via Brain Blogger Read More Here..Gut bacteria may play role in neurodegenerative diseases
| New findings could lead to new prevention methods Related items from OnMedica RA risk lower after urinary and gut infections Funeral directors could be more likely to develop ALS Gut bug linked to leanness and metabolic health Exercise boosts diversity of gut bacteria Mums report more gut symptoms in toddlers with autism |
Over 200 suicides occur in patients under crisis team care
| Mental health crisis teams under strain, report finds Related items from OnMedica Overdose death risk for discharged drug users Call for action as suicide rate rises Middle aged male mental health service users most at risk of suicide Tough disability assessments linked to rise in suicides Those bereaved through suicide, at risk of doing the same |
Breast cancer risk 'not increased' by night shifts
Guidance launched to protect nurses who work alone
| Almost half of community nurses have faced abuse Related items from OnMedica Abusive patient prosecuted District nursing care at ‘breaking point’ £10m plan to boost community mental health Primary Care Home has positive impact on care and services Scotland to legislate for ‘safe staffing’ levels |